Details for Patent: 11,266,796
✉ Email this page to a colleague
Which drugs does patent 11,266,796 protect, and when does it expire?
Patent 11,266,796 protects PROAIR DIGIHALER, AIRDUO DIGIHALER, and ARMONAIR DIGIHALER, and is included in three NDAs.
Protection for AIRDUO DIGIHALER has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has nineteen patent family members in ten countries.
Summary for Patent: 11,266,796
Title: | Inhalation device with integrated electronics |
Abstract: | A device (400) for delivering medication to a user includes a circular or elliptical body (410) that includes a mouthpiece (420), a flexible strip (401) of medication, a lever (424), and a mouthpiece cover (491), where the mouthpiece cover is rotatable about the body. An electronics module (120) includes a communication circuit (134), a power supply (126), a sensor system (128), and a switch. The lever is configured to actuate the switch when the lever is moved from a closed position to an open position. The lever is further configured to advance a dose of medication on the flexible strip when moved from the closed position to the open position. The switch switches the electronics module from an off state to an active state when the lever is actuated for a first time by a user. The electronics module is configured to not return to the off state thereafter. |
Inventor(s): | Yang; Dong (Waterford, IE), Moorhouse; Dylan A. (County Wexford, IE) |
Assignee: | Norton (Waterford) Limited (Waterford, IE) |
Application Number: | 16/463,838 |
Patent Claim Types: see list of patent claims | Use; Delivery; Device; | More… ↓ |
Drugs Protected by US Patent 11,266,796
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva Branded Pharm | PROAIR DIGIHALER | albuterol sulfate | POWDER, METERED;INHALATION | 205636-002 | Dec 21, 2018 | DISCN | Yes | No | 11,266,796 | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
Teva Pharm | AIRDUO DIGIHALER | fluticasone propionate; salmeterol xinafoate | POWDER;INHALATION | 208799-004 | Jul 12, 2019 | DISCN | Yes | No | 11,266,796*PED | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
Teva Pharm | AIRDUO DIGIHALER | fluticasone propionate; salmeterol xinafoate | POWDER;INHALATION | 208799-005 | Jul 12, 2019 | DISCN | Yes | No | 11,266,796*PED | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
Teva Pharm | AIRDUO DIGIHALER | fluticasone propionate; salmeterol xinafoate | POWDER;INHALATION | 208799-006 | Jul 12, 2019 | DISCN | Yes | No | 11,266,796*PED | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 11,266,796
PCT Information | |||
PCT Filed | December 05, 2017 | PCT Application Number: | PCT/EP2017/081452 |
PCT Publication Date: | June 14, 2018 | PCT Publication Number: | WO2018/104268 |
International Family Members for US Patent 11,266,796
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2017371122 | ⤷ Subscribe | |||
Australia | 2022287570 | ⤷ Subscribe | |||
Canada | 3045401 | ⤷ Subscribe | |||
China | 110461394 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |